US2011137012A1PendingUtilityA1
Cell culture method using amino acid-enriched medium
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Apr 26, 2007Filed: Apr 25, 2008Published: Jun 9, 2011
Est. expiryApr 26, 2027(~0.7 yrs left)· nominal 20-yr term from priority
Inventors:Satoshi KatayamaShouhei KishishitaKunihiko KodairaMakoto SadamitsuYoshinori TakagiHiroki Matsuda
A61P 37/04C12N 2510/02C07K 16/303C12N 2500/32C12N 5/0018C07K 16/2866C07K 2317/24C12P 21/02C12N 2500/33C12N 5/00C12N 5/10C12N 15/11C12P 21/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of culturing cells capable of producing desired proteins to obtain the proteins by use of a medium from which biological components are excluded as much as possible are provided. Specifically, a culture method characterized by culturing while maintaining a specific amino acid in a culture solution at a high concentration, and a cell culture fed-batch medium for use in the method are provided.
Claims
exact text as granted — not AI-modified1 . A method of culturing a cell characterized in that a concentration of serine in a culture solution is maintained at 1 mM or higher at least during a certain period after the onset of a cell growth phase, the method used in a process comprising culturing a cell that is capable of producing a desired protein to obtain the desired protein.
2 . The method of claim 1 , further characterized in that a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or at 0.4 mM or higher at least during the certain period after the onset of the cell growth phase.
3 . A medium for animal cell culture, comprising at least 1 mM of serine or a salt thereof.
4 . The medium for animal cell culture of claim 3 , further comprising at least 1 mM of tyrosine and/or at least 0.4 mM of cysteine.
5 . A process of producing a desired protein, comprising culturing a cell that is capable of producing the desired protein, by use of the medium of claim 3 to obtain the desired protein.
6 . A method of culturing a cell, the method used in a process comprising culturing a cell that is capable of producing a desired protein to obtain the desired protein, the method characterized in that a concentration of serine in a culture solution is maintained at 1 mM or higher at least during a part of or an entire period sufficient to enable the cell that is to be cultured to grow sufficiently, or during a part of or an entire period sufficient to enable adequate production of the desired protein that is to be produced.
7 . The method of claim 6 , further characterized in that a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or at 0.4 mM or higher at least during a part of or the entire period sufficient to enable the cell that is to be cultured to grow sufficiently, or during a part of or the entire period sufficient to enable adequate production of the desired protein that is to be produced.
8 . A method of culturing a cell, characterized in that a concentration of serine in a culture solution is maintained at 1 mM or higher at least during a part of or an entire period of an exponential cell growth phase, the method used in a process comprising culturing a cell that is capable of producing a desired protein to obtain the desired protein.
9 . The method of claim 8 , further characterized in that a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or higher or at 0.4 mM or higher at least during a part of or an entire period of the exponential cell growth phase.
10 . The method of claim 8 , wherein the concentration of serine in the culture solution is maintained at 2 mM or higher at least during a part of or an entire period of the exponential cell growth phase.
11 . A method of culturing a cell, characterized in that a concentration of serine in a culture solution is maintained at 1 mM or higher at least during a part of or an entire period from a third day to a tenth day of the culture, the method used in a process comprising culturing a cell that is capable of producing a desired protein to obtain the desired protein.
12 . The method of claim 11 , further characterized in that a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or higher or at 0.4 mM or higher at least during a part of or an entire period from the third day to the tenth day of the culture.
13 . The method of claim 11 , wherein the concentration of serine in the culture solution is maintained at 2 mM or higher at least during a part of or an entire period from the third day to the tenth day of the culture.
14 . The method of claim 1 , wherein the cell is cultured by batch culture, repeated batch culture, fed-batch culture, repeated fed-batch culture, continuous culture, or perfusion culture.
15 . The method of claim 1 , wherein the cell is cultured by fed-batch culture.
16 . The method or process according to claim 15 , wherein the serine and tyrosine and/or cysteine are fed into the culture solution in multiple batches sequentially or continuously.
17 . The method of claim 1 , wherein the cell is transformed with a gene encoding the desired protein.
18 . The method or process of claim 17 , wherein the desired protein is an antibody.
19 . The method of claim 1 , wherein the cell is a mammal cell.
20 . The method of claim 19 , wherein the mammal cell is a CHO cell.
21 . A fed-batch medium for culturing a cell, comprising serine at a concentration of 10 mM to 1000 mM.
22 . A fed-batch medium for culturing a cell, comprising serine at a concentration of 20 mM to 500 mM.
23 . The fed-batch medium of claim 21 , further comprising cysteine and/or tyrosine.
24 . The fed-batch medium of claim 21 , further comprising cysteine and tyrosine.
25 . A method of culturing a cell by fed-batch culture, comprising adding the fed-batch medium of claim 21 .
26 . A process of producing a desired protein by culturing a cell, comprising culturing a cell using the method of claim 1 .
27 . A preparation process of a medicament comprising as an active ingredient a protein produced by the process of claim 5 .Join the waitlist — get patent alerts
Track US2011137012A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.